Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00158613 · ClinicalTrials.gov registry record · Phase 4
Study of the Treatment of Articular Repair (STAR)
A Phase 4 study, sponsored by Vericel Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 126
- Enrollment target
NCT00158613: Completed Phase 4 study, sponsored by Vericel Corporation.
NCT00158613 is a Phase 4 study that has completed, run by Vericel Corporation. The registered enrollment target is 126 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00158613, a Phase 4 study, has completed, sponsored by Vericel Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 126 participants
- Enrollment target
Study Summary
This study is a prospective, longitudinal, multi-center, within patient evaluation of patients with articular cartilage defects of the knee who have had an inadequate response to a prior non-Carticel surgical treatment. Patients who met eligibility criteria were enrolled in the study. Subsequent to implantation with Carticel patients have follow-up every 6-months up to 48-months.
Interventions
- BIOLOGICAL Carticel (autologous cultured chondrocyte) implantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2000-03 |
| Est. Completion | 2005-11 |
| Phase | Phase 4 |
What the finished NCT00158613 record still lists
NCT00158613 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 1 intervention - of which Carticel (autologous cultured chondrocyte) implantation is the first listed.
NCT00158613 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00158613 about?
NCT00158613 is a clinical study titled "Study of the Treatment of Articular Repair (STAR)". This study is a prospective, longitudinal, multi-center, within patient evaluation of patients with articular cartilage defects of the knee who have had an inadequate response to a prior non-Carticel surgical treatment. Patients who met eligibility criteria were enrolled in the study. Subsequent to ...
What is the current status of trial NCT00158613?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 126 participants. The study started on 2000-03. Estimated completion is 2005-11.
What interventions are being tested in trial NCT00158613?
The interventions under investigation include: Carticel (autologous cultured chondrocyte) implantation (BIOLOGICAL).
Who is sponsoring clinical trial NCT00158613?
This trial is sponsored by Vericel Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00158613's enrollment target sits among peer trials
126 646th of 2000 higher than 1,354 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia